![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Pumas-AI, a science-first organization that turns data into life-saving decisions faster, announced that its Pumas software is now available for desktop download. Pumas is a one-stop integrated modeling and simulation platform designed to multiply productivity across the drug development lifecycle, turning data into life-saving decisions faster.
Pumas provides all the analyses that pharmaceutical scientists need on a single, integrated platform, and key features and benefits include:
- Flexible access for those who want it to on the move
- The same functionalities and syntax to allow easy transition to Pumas cloud solutions
- An on-premise application that does not require an Internet connection
“Scientists created this modeling and simulation software for other scientists to make their lives easier and provide more think time,” said Dr. Joga Gobburu, CEO at Pumas-AI, and former U.S. Food and Drug Administration (FDA) Director, Division of Pharmacometrics. “With this powerful software now available on desktop, scientists have another option especially those who are looking for access on the move.”
With a complete range of analytics capabilities, Pumas gives pharma and biotech companies and their investors usable quantitative metrics on technical, regulatory, and commercial success probabilities. Users can translate predictive insight into real world decisions faster than ever before, effectively de-risking investments.
Co-founder and Chief Scientific Officer Vijay Ivaturi, Ph.D. added, “Thousands of users are already taking advantage of the unprecedented speed and accuracy that Pumas provides, leaving behind age-old software that is making them jump between multiple systems and manual processes.”
Modeling and simulation results generated on Pumas are increasingly being submitted to and accepted by regulatory agencies.
